Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q451
SBA

SBA — Single Best Answer · Review

Question 451

Pharmacology → General

NextGen Workflow Status Needs Review
SQL status generated
Destination eBook
Type SSBA
UUID 61b051b8-8877-4bbc-9391-c21c0f5528f4

Classification

Speciality
Obstetrics and Gynaecology
Group
Basic
Title
Pharmacology
Topic
General
Subtopic 1
Antidepressant Drugs
Subtopic 2
Tricyclic antidepressants
Subtopic 3
Toxicity profile
Question Type
SBA

Question

SSBA
Question Header
A patient taking amitriptyline develops dry mouth, urinary retention and palpitations. Which additional serious complication is associated with this drug class?
Question Stem
Select the single best answer.

Options

A Profound hypoglycaemia from beta-cell stimulation
B Severe rebound hypertension after abrupt withdrawal
C Arrhythmias and heart block
D Premature closure of the ductus arteriosus
E Hyperkalaemia due to epithelial sodium-channel inhibition

Explanation

Tricyclic antidepressants produce prominent anticholinergic adverse effects including dry mouth, constipation, urinary retention, blurred vision and palpitations. Tricyclic antidepressants may also cause serious arrhythmias and heart block, particularly with amitriptyline, and have a relatively low safety margin in overdose.

Option Validity

A) Hypoglycaemia is associated with glucose-lowering drugs such as sulphonylureas rather than tricyclic antidepressant toxicity.

B) Severe rebound hypertension following abrupt withdrawal is described for clonidine.

D) Premature ductal closure is a concern associated with NSAID exposure in late pregnancy.

E) Potassium retention due to distal sodium-channel inhibition relates to potassium-sparing diuretics.

Further Reading

Saxena R. Textbook for MRCOG-1. Chapter 12: Pharmacology. Antidepressant Drugs, pp.346–347.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
—
Destination
eBook
Source
Saxena - MRCOG-1 Basic Sciences - Pharmacology - General
Source Section
Antidepressant Drugs
Source Locator
Chapter 12, pp.346–347
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question